
  
    
      
        Background_NNP
        The_DT need_NN for_IN technologies_NNS that_WDT allow_VBP highly_RB parallel_JJ
        quantitation_NN of_IN specific_JJ proteins_NNS in_IN a_DT rapid_JJ ,_, low-cost_JJ and_CC
        low-sample-volume_JJ format_NN has_VBZ become_VBN increasingly_RB apparent_JJ
        with_IN the_DT growing_VBG recognition_NN of_IN the_DT importance_NN of_IN global_JJ
        approaches_NNS to_TO molecular_JJ characterization_NN of_IN physiology_NN ,_,
        development_NN ,_, and_CC disease_NN [_NN 1_CD ,_, 2_CD ]_NN ._. The_DT ability_NN to_TO quantitate_NN
        multiple_JJ proteins_NNS simultaneously_RB has_VBZ applications_NNS in_IN basic_JJ
        biological_JJ research_NN ,_, molecular_JJ classification_NN and_CC diagnosis_NN
        of_IN disease_NN ,_, identification_NN of_IN therapeutic_JJ markers_NNS and_CC
        targets_NNS ,_, and_CC profiling_VBG of_IN response_NN to_TO toxins_NNS and_CC
        pharmaceuticals_NNS ._. Many_JJ standard_JJ assays_NNS are_VBP amenable_JJ to_TO
        parallel_VB analysis_NN in_IN microtiter_NN plates_NNS ,_, but_CC sample_NN and_CC
        reagent_NN consumption_NN can_MD be_VB prohibitive_JJ in_IN large-scale_JJ
        studies_NNS ._. Two-dimensional_NNP gels_NNS are_VBP now_RB widely_RB used_VBN for_IN
        large-scale_JJ protein_NN analysis_NN in_IN cancer_NN research_NN [_NN 3_CD ]_NN and_CC
        other_JJ areas_NNS of_IN biology_NN [_NN 4_CD ]_NN ._. Two-dimensional_NNP gels_NNS have_VBP been_VBN
        used_VBN to_TO separate_VB and_CC visualize_VB 2_CD ,_, 000_CD -_: 10_CD ,_, 000_CD proteins_NNS in_IN a_DT
        single_JJ experiment_NN [_NN 5_CD ]_NN ,_, and_CC subsequent_JJ excision_NN of_IN protein_NN
        bands_NNS and_CC detection_NN by_IN mass_NN spectrometry_NN can_MD enable_VB
        identification_NN of_IN the_DT proteins_NNS [_NN 6_CD ]_NN ._.
        Ordered_NNP arrays_NNS of_IN peptides_NNS and_CC proteins_NNS provide_VBP the_DT
        basis_NN of_IN another_DT strategy_NN for_IN parallel_JJ protein_NN analysis_NN ._.
        DNA_NN microarrays_NNS have_VBP demonstrated_VBN the_DT effectiveness_NN of_IN this_DT
        approach_NN in_IN many_JJ areas_NNS of_IN biological_JJ research_NN (_( see_VB [_NN 7_CD ,_, 8_CD ,_,
        9_CD ]_NN for_IN reviews_NNS )_) ._. Protein_NNP assays_NNS using_VBG ordered_VBN arrays_NNS have_VBP
        been_VBN explored_JJ since_IN the_DT development_NN of_IN multipin_NN synthesis_NN [_NN
        10_CD ]_NN and_CC spot_NN synthesis_NN [_NN 11_CD ]_NN of_IN peptides_NNS on_IN cellulose_NN
        supports_NNS ._. Protein_NNP arrays_NNS on_IN membranes_NNS have_VBP been_VBN used_VBN to_TO
        screen_VB binding_JJ specificities_NNS of_IN a_DT protein_NN expression_NN
        library_NN [_NN 12_CD ,_, 13_CD ,_, 14_CD ]_NN and_CC to_TO detect_VB DNA-_NNP ,_, RNA-_NNP ,_, and_CC
        protein-binding_JJ targets_NNS [_NN 15_CD ]_NN ._. Arrays_NNP of_IN clones_NNS from_IN
        phage-display_JJ libraries_NNS can_MD be_VB probed_JJ with_IN an_DT
        antigen-coated_JJ filter_NN for_IN high-throughput_JJ antibody_NN
        screening_NN [_NN 16_CD ]_NN ._. Antibodies_NNP bound_VBN to_TO glass_NN can_MD be_VB used_VBN as_IN a_DT
        flow-cell_JJ array_NN immunosensor_NN [_NN 17_CD ]_NN ,_, and_CC antibodies_NNS spotted_VBD
        into_IN glass-bottom_JJ microwells_NNS have_VBP been_VBN used_VBN for_IN
        miniaturized_VBN ,_, high-throughput_JJ ELISA_NNP [_NN 18_CD ]_NN ._. Multiple_NNP
        antigens_NNS and_CC antibodies_NNS have_VBP been_VBN patterned_VBN onto_IN
        polystyrene_NN using_VBG a_DT desktop_NN jet_NN printer_NN [_NN 19_CD ]_NN and_CC onto_IN
        glass_NN by_IN covalent_NN attachment_NN to_TO polyacrylamide_NN gel_NN pads_NNS [_NN
        20_CD ]_NN for_IN parallel_JJ immunoassays_NNS ._. Proteins_NNPS covalently_RB attached_VBN
        to_TO glass_NN slides_NNS through_IN aldehyde-containing_JJ silane_NN reagents_NNS
        have_VBP been_VBN used_VBN to_TO detect_VB protein-protein_JJ interactions_NNS ,_,
        enzymatic_JJ targets_NNS ,_, and_CC protein-small_JJ molecule_NN interactions_NNS
        [_NN 21_CD ]_NN ._.
        We_PRP explored_JJ the_DT use_NN of_IN protein_NN microarrays_NNS for_IN the_DT
        highly_RB parallel_JJ quantitation_NN of_IN proteins_NNS in_IN complex_JJ
        mixtures_NNS ._. A_DT robotic_JJ arrayer_NN was_VBD used_VBN to_TO print_VB protein_NN
        solutions_NNS onto_IN the_DT surface_NN of_IN a_DT coated_JJ microscope_NN slide_NN in_IN
        an_DT ordered_VBN array_NN ._. This_DT array_NN provides_VBZ specific_JJ binding_JJ
        sites_NNS for_IN proteins_NNS that_IN we_PRP wish_VBP to_TO measure_VB in_IN complex_JJ
        samples_NNS ._. Protein_NNP solutions_NNS to_TO be_VB measured_VBN are_VBP labeled_VBN by_IN
        covalent_NN linkage_NN of_IN a_DT fluorescent_NN dye_NN to_TO the_DT amino_JJ groups_NNS
        on_IN the_DT proteins_NNS ._. The_DT labeled_VBN solutions_NNS are_VBP placed_VBN on_IN
        arrays_NNS ,_, and_CC specific_JJ binding_JJ interactions_NNS (_( for_IN example_NN ,_,
        antibody-antigen_JJ interactions_NNS )_) result_NN in_IN localizing_VBG
        specific_JJ individual_JJ components_NNS of_IN the_DT complex_JJ mixtures_NNS to_TO
        the_DT corresponding_JJ specific_JJ spots_NNS in_IN the_DT array_NN ._. To_TO maximize_VB
        the_DT robustness_NNS and_CC quantitative_JJ accuracy_NN of_IN the_DT array_NN ,_,
        comparative_JJ fluorescence_NN measurements_NNS are_VBP made_VBN ,_, using_VBG an_DT
        internal_JJ standard_NN for_IN each_DT protein_NN to_TO be_VB assayed_JJ ._. Two_CD
        differentially_RB labeled_VBN protein_NN solutions_NNS are_VBP mixed_JJ together_RB
        and_CC then_RB incubated_JJ with_IN the_DT array_NN so_IN that_IN the_DT fluorescence_NN
        ratio_NN at_IN each_DT spot_NN corresponds_NNS to_TO the_DT concentration_NN ratio_NN
        of_IN each_DT protein_NN in_IN the_DT two_CD protein_NN solutions_NNS ._. We_PRP
        characterized_VBD the_DT performance_NN of_IN the_DT protein_NN microarrays_NNS
        with_IN approximately_RB 115_CD antibody_NN /_NN antigen_NN pairs_NNS ,_, using_VBG both_DT
        printed_VBN arrays_NNS of_IN antibodies_NNS to_TO detect_VB antigens_NNS and_CC printed_VBN
        arrays_NNS of_IN antigens_NNS to_TO detect_VB antibodies_NNS ._. To_TO assess_VB the_DT
        applicability_NN of_IN this_DT method_NN to_TO real-world_JJ samples_NNS ,_, we_PRP
        examined_VBD protein_NN microarray_NN detection_NN in_IN various_JJ
        concentration_NN ranges_NNS and_CC background_NN conditions_NNS ._.
      
      
        Results_NNS
        
          Using_VBG antibody_NN and_CC antigen_NN arrays_NNS to_TO measure_VB
          variation_NN in_IN protein_NN concentrations_NNS
          We_PRP assembled_VBD a_DT set_NN of_IN 115_CD antibody_NN /_NN antigen_NN pairs_NNS to_TO
          evaluate_VB the_DT use_NN of_IN protein_NN microarrays_NNS for_IN specific_JJ
          detection_NN and_CC quantitation_NN of_IN multiple_JJ proteins_NNS in_IN
          complex_JJ mixtures_NNS ._. Microarrays_NNP were_VBD constructed_VBN by_IN
          printing_VBG microscopic_JJ spots_NNS of_IN either_DT antibodies_NNS (_( to_TO
          detect_VB antigens_NNS )_) or_CC antigens_NNS (_( to_TO detect_VB antibodies_NNS )_) onto_IN
          a_DT modified_VBN glass_NN surface_NN ._. The_DT microarrays_NNS contained_VBD six_CD
          to_TO twelve_CD spots_NNS of_IN each_DT antibody_NN or_CC antigen_NN ,_, about_IN 1_CD ,_, 100_CD
          spots_NNS all_DT together_RB ._. We_PRP performed_VBD controlled_VBN experiments_NNS
          to_TO measure_VB the_DT specificity_NN of_IN binding_VBG ,_, the_DT accuracy_NN and_CC
          precision_NN of_IN quantitation_NN ,_, and_CC the_DT detection_NN limits_NNS ._. Six_CD
          different_JJ mixtures_NNS of_IN the_DT 115_CD antibodies_NNS and_CC six_CD
          different_JJ mixtures_NNS of_IN 115_CD antigens_NNS were_VBD prepared_VBN so_IN that_IN
          the_DT concentration_NN of_IN each_DT species_NNS varied_VBD in_IN a_DT unique_JJ
          pattern_NN across_IN the_DT protein_NN mixtures_NNS over_IN a_DT range_NN of_IN three_CD
          orders_NNS of_IN magnitude_NN ._. Each_DT of_IN the_DT six_CD protein_NN mixtures_NNS was_VBD
          labeled_VBN with_IN the_DT dye_NN Cy_NNP 5_CD (_( red_JJ fluorescence_NN )_) and_CC then_RB
          mixed_VBN with_IN a_DT Cy_NNP 3_CD -_: labeled_VBN (_( green_JJ fluorescence_NN )_) '_POS reference_NN '_''
          mixture_NN containing_VBG each_DT of_IN the_DT same_JJ 115_CD proteins_NNS at_IN a_DT
          constant_JJ concentration_NN ._. The_DT variation_NN across_IN the_DT six_CD
          microarrays_NNS in_IN the_DT red-to-green_JJ (_( R_NN /_NN G_NNP )_) ratio_NN measured_VBN for_IN
          each_DT antibody_NN or_CC antigen_NN spot_NN should_MD reflect_VB the_DT
          variation_NN in_IN the_DT concentration_NN of_IN the_DT corresponding_JJ
          binding_JJ partner_NN in_IN the_DT set_NN of_IN mixes_VBZ ._. By_IN comparing_VBG the_DT
          observed_VBN variation_NN in_IN the_DT concentration_NN ratios_NNS with_IN the_DT
          known_VBN variation_NN in_IN the_DT concentration_NN ratios_NNS ,_, we_PRP could_MD
          assay_NN the_DT performance_NN of_IN each_DT antibody_NN /_NN antigen_NN pair_NN ._.
          Six_CD antibody_NN arrays_NNS were_VBD used_VBN to_TO analyze_VB a_DT set_NN of_IN six_CD
          unique_JJ antigen_NN mixes_VBZ (_( Figure_NN 1_LS )_) ._. Each_DT antigen_NN ranged_VBD in_IN
          concentration_NN from_IN 1_CD ._. 6_CD μg_NN /_NN ml_NN to_TO 1_CD ._. 6_CD ng_NN /_NN ml_NN ._. The_DT
          concentration_NN of_IN each_DT antigen_NN in_IN the_DT reference_NN mixture_NN
          was_VBD 0_CD ._. 17_CD μg_NN /_NN ml_NN ._. The_DT inset_NN in_IN each_DT panel_NN highlights_VBZ
          anti-_NN Flag_NNP and_CC anti-_NN IgG_NNP spots_NNS ,_, and_CC the_DT labels_NNS indicate_VBP the_DT
          concentration_NN of_IN the_DT antigen_NN applied_VBN to_TO each_DT array_NN ._. The_DT
          images_NNS were_VBD produced_VBN by_IN merging_VBG an_DT image_NN taken_VBN with_IN the_DT
          Cy_NNP 3_CD -_: selective_JJ filter_NN ,_, represented_VBD as_IN green_JJ ,_, with_IN an_DT image_NN
          taken_VBN with_IN a_DT Cy_NNP 5_CD -_: selective_JJ filter_NN ,_, represented_VBD as_IN red_NN ._. At_IN
          the_DT highest_JJS concentration_NN (_( 1_CD ._. 6_CD μg_NN /_NN ml_NN )_) ,_, the_DT Cy_NNP 5_CD -_: labeled_VBN
          antigen_NN was_VBD ten-fold_JJ more_RBR abundant_JJ than_IN the_DT Cy_NNP 3_CD -_: labeled_VBN
          antigen_NN ,_, and_CC both_DT the_DT anti-_NN Flag_NNP (_( Figure_NN 1_CD ;_: panel_NN 4_LS )_) and_CC
          anti-_NN IgG_NNP (_( Figure_NN 1_CD ;_: panel_NN 3_LS )_) spots_NNS appeared_VBD red_JJ ._. At_IN
          progressively_RB lower_JJR concentrations_NNS ,_, the_DT color_NN of_IN the_DT
          spots_NNS appeared_VBD more_RBR yellow_JJ ,_, and_CC at_IN the_DT lowest_JJS
          concentration_NN of_IN 1_CD ._. 6_CD ng_NN /_NN ml_NN (_( Figure_NN 1_CD panel_NN 3_CD for_IN anti-_NN Flag_NNP
          and_CC Figure_NN 1_CD panel_NN 6_CD for_IN anti-_NN IgG_NNP )_) ,_, the_DT spots_NNS appeared_VBD
          green_JJ ._. These_DT color_NN changes_NNS provided_VBD visual_JJ confirmation_NN
          that_IN the_DT spotted_VBN antibodies_NNS specifically_RB detected_VBD
          variation_NN in_IN concentration_NN of_IN their_PRP$ respective_JJ
          antigens_NNS ._.
          In_IN a_DT complementary_JJ experiment_NN ,_, six_CD different_JJ
          Cy_NNP 5_CD -_: labeled_VBN antibody_NN mixes_VBZ were_VBD compared_VBN to_TO a_DT constant_JJ
          Cy_NNP 3_CD -_: labeled_VBN reference_NN antibody_NN mix_NN using_VBG six_CD antigen_NN
          arrays_NNS (_( Figure_NN 2_LS )_) ._. The_DT inset_NN in_IN each_DT panel_NN highlights_VBZ
          AIM_NNP 1_CD and_CC Kalanin_NNP B_NNP 1_CD spots_NNS detecting_VBG the_DT indicated_VBD
          concentrations_NNS of_IN corresponding_JJ antibody_NN ._. Like_IN the_DT
          antibody_NN spots_NNS ,_, the_DT color_NN of_IN the_DT antigen_NN spots_NNS varied_VBD
          appropriately_RB with_IN variation_NN in_IN the_DT concentration_NN of_IN the_DT
          corresponding_JJ binding_JJ partner_NN ,_, providing_VBG evidence_NN that_IN
          these_DT spotted_VBN antigens_NNS specifically_RB detected_VBD their_PRP$
          respective_JJ antibodies_NNS ._.
          To_TO assess_VB performance_NN more_RBR quantitatively_RB ,_, the_DT log_NN 
          10_CD of_IN the_DT red-to-green_JJ ratio_NN (_( log_VB 
          10_CD (_( R_NN /_NN G_NNP )_) )_) for_IN each_DT antibody_NN spot_NN was_VBD
          analyzed_VBN as_IN a_DT function_NN of_IN the_DT concentration_NN of_IN the_DT
          cognate_NN antigen_NN (_( Figure_NN 3_LS )_) ._. For_IN each_DT of_IN the_DT 12_CD antibodies_NNS
          depicted_VBN ,_, the_DT median_JJ log_NN 
          10_CD (_( R_NN /_NN G_NNP )_) of_IN the_DT nine_CD to_TO twelve_CD
          replicate_VB spots_NNS is_VBZ plotted_VBD ._. The_DT error_NN bars_NNS represent_VBP the_DT
          standard_JJ deviation_NN in_IN the_DT log_NN 
          10_CD (_( R_NN /_NN G_NNP )_) ._. The_DT dashed_VBN lines_NNS represent_VBP
          the_DT log_NN 
          10_CD of_IN the_DT true_JJ ratios_NNS of_IN the_DT antigen_NN
          concentrations_NNS in_IN the_DT two_CD mixes_VBZ ._. For_IN several_JJ of_IN the_DT
          antibodies_NNS ,_, for_IN example_NN ,_, anti-_NN MEKK_NNP 3_CD and_CC anti-_NN HCG_NNP ,_, the_DT
          results_NNS closely_RB paralleled_JJ the_DT ideal_JJ (_( dashed_VBN line_NN )_) over_IN
          the_DT entire_JJ range_NN of_IN concentrations_NNS ._. Several_JJ antibodies_NNS ,_,
          for_IN example_NN ,_, SOD_NNP and_CC MAP_NNP 4_CD ,_, showed_VBD a_DT nearly_RB ideal_JJ response_NN
          at_IN high_JJ concentrations_NNS ,_, but_CC deviated_VBD from_IN linearity_NN at_IN
          low_JJ concentrations_NNS ._. The_DT plateau_NN at_IN low_JJ concentrations_NNS
          corresponds_NNS to_TO the_DT fluorescence_NN signal_NN in_IN the_DT Cy_NNP 5_CD (_( red_JJ )_)
          channel_NN approaching_VBG the_DT background_NN ,_, indicating_VBG a_DT
          detection_NN limit_NN of_IN about_IN 5_CD ng_NN /_NN ml_NN for_IN SOD_NNP and_CC MAP_NNP 4_CD ._. For_IN
          each_DT antibody_NN depicted_VBN in_IN Figure_NN 3_CD ,_, the_DT R_NN /_NN G_NNP ratio_NN was_VBD
          very_RB similar_JJ among_IN the_DT replicate_VB spots_NNS ,_, evidenced_VBN by_IN the_DT
          small_JJ error_NN bars_NNS ._. At_IN low_JJ concentrations_NNS of_IN cognate_NN
          antigen_NN ,_, the_DT ratio_NN measured_VBN for_IN replicate_VB spots_NNS typically_RB
          showed_VBD increased_VBN dispersion_NN ,_, as_IN with_IN anti-_NN MEKK_NNP 3_CD and_CC
          anti-_NN SIN_NNP ,_, and_CC in_IN some_DT cases_VBZ the_DT ratio_NN could_MD not_RB be_VB
          measured_VBN (_( that_WDT is_VBZ ,_, the_DT Cy_NNP 5_CD signal_NN was_VBD below_IN background_NN )_) ._.
          The_DT complete_JJ data_NN set_VBN ,_, including_VBG primary_JJ images_NNS and_CC
          quantitative_JJ data_NNS for_IN all_PDT the_DT antibodies_NNS and_CC antigens_NNS
          tested_VBN ,_, can_MD be_VB found_VBN at_IN [_NN 22_CD ]_NN and_CC as_IN Additional_JJ data_NNS
          files_NNS available_JJ with_IN the_DT online_NN version_NN of_IN this_DT
          article_NN ._.
          The_DT deviations_NNS from_IN linearity_NN were_VBD usually_RB consistent_JJ
          among_IN all_PDT the_DT replicate_VB spots_NNS ._. For_IN example_NN ,_, all_DT of_IN the_DT
          anti-_NN HCG_NNP spots_NNS showed_VBD a_DT slight_JJ positive_JJ deviation_NN at_IN the_DT
          25_CD ng_NN /_NN ml_NN dilution_NN ,_, and_CC all_DT of_IN the_DT anti-_NN Per_IN 2_CD spots_NNS showed_VBD
          a_DT slight_JJ positive_JJ deviation_NN at_IN the_DT 400_CD ng_NN /_NN ml_NN dilution_NN ._.
          For_IN two_CD of_IN the_DT antigens_NNS ,_, HCG_NNP and_CC Human_NNP IgG_NNP ,_, two_CD
          independent_JJ antibodies_NNS were_VBD printed_VBN ,_, and_CC in_IN both_DT cases_NNS ,_,
          the_DT deviations_NNS from_IN linearity_NN were_VBD highly_RB consistent_JJ
          between_IN the_DT antibodies_NNS with_IN the_DT same_JJ specificity_NN ._. These_DT
          close_NN ratios_NNS suggest_VBP that_IN the_DT errors_NNS reflect_VBP deficiencies_NNS
          in_IN the_DT preparation_NN of_IN the_DT antigen_NN solutions_NNS ,_, such_JJ as_IN
          pipetting_VBG errors_NNS or_CC inconsistencies_NNS in_IN the_DT dye-labeling_JJ
          reaction_NN ._. Additional_JJ results_NNS pointed_VBD to_TO variation_NN in_IN the_DT
          labeling_VBG reactions_NNS as_IN the_DT most_RBS likely_JJ source_NN of_IN
          variation_NN ;_: when_WRB we_PRP repeated_VBD an_DT experiment_NN using_VBG the_DT same_JJ
          labeling_VBG reaction_NN ,_, the_DT shape_NN of_IN the_DT curve_NN relating_VBG
          fluorescence_NN ratio_NN to_TO concentration_NN remained_VBD the_DT same_JJ for_IN
          each_DT antibody_NN /_NN antigen_NN pair_NN ._. However_RB ,_, when_WRB the_DT same_JJ
          antigen_NN mixes_VBZ were_VBD relabeled_JJ under_IN slightly_RB different_JJ
          conditions_NNS ,_, the_DT curve_NN shape_NN changed_VBN (_( data_NNS not_RB shown_VBN )_) ._.
          Thus_RB variation_NN in_IN labeling_VBG appears_VBZ to_TO be_VB a_DT more_RBR important_JJ
          source_NN of_IN imprecision_NN in_IN the_DT measurements_NNS than_IN
          cross-reactivity_JJ of_IN antigen_NN /_NN antibody_NN pairs_NNS or_CC dilution_NN
          errors_NNS ,_, which_WDT would_MD be_VB expected_VBN to_TO be_VB consistent_JJ among_IN
          all_DT experiments_NNS using_VBG the_DT same_JJ antigen_NN mix_NN ._. As_IN the_DT
          protein_NN labeling_VBG reaction_NN is_VBZ sensitive_JJ to_TO changes_NNS in_IN pH_NN ,_,
          local_JJ environment_NN of_IN reactive_JJ amines_NNS ,_, and_CC the_DT
          concentrations_NNS of_IN other_JJ reactive_JJ species_NNS ,_, the_DT efficiency_NN
          of_IN the_DT conjugation_NN of_IN the_DT dye_NN to_TO each_DT protein_NN may_MD be_VB
          variable_JJ among_IN the_DT proteins_NNS in_IN each_DT mixture_NN in_IN a_DT way_NN that_WDT
          varies_VBZ from_IN one_CD labeling_VBG reaction_NN to_TO another_DT ._. Including_VBG a_DT
          diverse_JJ set_NN of_IN internal_JJ control_NN proteins_NNS in_IN the_DT protein_NN
          mixture_NN to_TO be_VB labeled_VBN could_MD provide_VB a_DT way_NN to_TO correct_VB for_IN
          this_DT source_NN of_IN measurement_NN error_NN ._. Modification_NNP and_CC
          careful_JJ control_NN of_IN the_DT labeling_VBG reaction_NN should_MD lead_VB to_TO
          improvement_NN in_IN performance_NN ._.
          Many_JJ of_IN the_DT antibody_NN spots_NNS that_WDT showed_VBD significant_JJ
          deviations_NNS from_IN ideal_JJ performance_NN still_RB provided_VBD reliable_JJ
          qualitative_JJ or_CC semi-quantitative_JJ measurements_NNS ._. For_IN
          example_NN ,_, although_IN the_DT slope_NN of_IN the_DT Mint_NNP 2_CD response_NN curve_NN
          between_IN 1_CD ,_, 600_CD ng_NN /_NN ml_NN and_CC 400_CD ng_NN /_NN ml_NN was_VBD three-fold_JJ greater_JJR
          than_IN the_DT slope_NN of_IN the_DT ideal_JJ line_NN ,_, the_DT fluorescence_NN ratio_NN
          varied_VBD monotonically_RB with_IN the_DT concentration_NN ratio_NN over_IN
          the_DT entire_JJ range_NN tested_VBN ._. The_DT horizontal_NN dashed_VBD line_NN in_IN
          the_DT graph_NN of_IN the_DT Mint_NNP 2_CD response_NN represents_VBZ a_DT R_NN /_NN G_NNP ratio_NN
          two_CD standard_JJ deviations_NNS above_IN the_DT value_NN measured_VBN at_IN the_DT
          final_JJ dilution_NN ._. Such_JJ a_DT threshold_NN is_VBZ useful_JJ for_IN defining_VBG a_DT
          fluorescence_NN ratio_NN that_WDT would_MD signify_VB the_DT presence_NN of_IN an_DT
          antigen_NN ._. All_DT of_IN the_DT fluorescence_NN ratios_NNS measured_VBN at_IN the_DT
          Mint_NNP 2_CD spots_NNS exceeded_VBD this_DT detection_NN threshold_NN when_WRB the_DT
          cognate_NN antigen_NN was_VBD present_JJ at_IN concentrations_NNS of_IN 30_CD ng_NN /_NN ml_NN
          or_CC higher_JJR ._. Thus_RB ,_, this_DT antibody_NN could_MD be_VB used_VBN in_IN a_DT
          microarray_NN format_NN for_IN detection_NN and_CC approximate_JJ
          quantitation_NN of_IN Mint_NNP 2_CD levels_NNS above_IN this_DT threshold_NN ._.
          The_DT performance_NN of_IN antigen_NN microarrays_NNS in_IN detecting_VBG
          and_CC measuring_VBG the_DT cognate_NN antibodies_NNS was_VBD analyzed_VBN in_IN a_DT
          similar_JJ way_NN (_( Figure_NN 4_LS )_) ._. For_IN many_JJ of_IN the_DT antigens_NNS ,_, the_DT
          experimental_JJ data_NN very_RB closely_RB follow_VB the_DT ideal_JJ response_NN
          (_( represented_VBN by_IN the_DT dashed_VBN line_NN )_) ._. For_IN antigens_NNS such_JJ as_IN
          P_NN 38_CD delta_NN ,_, Numb_NNP ,_, and_CC AIM-_NNP 1_CD ,_, we_PRP obtained_VBD reproducible_JJ and_CC
          accurate_JJ measurements_NNS over_IN the_DT entire_JJ concentration_NN range_NN
          (_( Figure_NN 4_LS )_) ._. These_DT antigens_NNS have_VBP detection_NN limits_NNS of_IN less_JJR
          than_IN 1_CD ng_NN /_NN ml_NN for_IN their_PRP$ respective_JJ antibodies_NNS ._. An_DT upward_JJ
          deviation_NN from_IN ideal_NN was_VBD occasionally_RB observed_VBN at_IN the_DT
          lower_JJR concentrations_NNS ,_, as_IN the_DT detection_NN limit_NN was_VBD
          approached_VBN ._. The_DT ratios_NNS measured_VBN at_IN replicate_VB spots_NNS were_VBD
          highly_RB consistent_JJ and_CC exhibited_VBN coordinated_VBN deviations_NNS
          from_IN linearity_NN ,_, except_IN in_IN some_DT cases_NNS at_IN low_JJ
          concentrations_NNS where_WRB the_DT dispersion_NN appeared_VBD more_RBR random_JJ
          (_( for_IN example_NN ,_, G_NNP 3_CD BP_NNP and_CC ARNT_NNP 1_LS )_) ._.
          To_TO summarize_VB the_DT overall_JJ performance_NN of_IN the_DT protein_NN
          arrays_NNS for_IN the_DT 115_CD antibody_NN /_NN antigen_NN pairs_NNS used_VBN in_IN this_DT
          study_NN ,_, the_DT number_NN of_IN antibodies_NNS and_CC antigens_NNS that_WDT met_VBD
          certain_JJ criteria_NNS for_IN qualitative_JJ and_CC quantitative_JJ
          performance_NN are_VBP represented_VBN in_IN Figure_NN 5_CD as_IN a_DT function_NN of_IN
          the_DT concentration_NN of_IN the_DT target_NN protein_NN in_IN a_DT complex_JJ
          solution_NN ._. The_DT standard_NN for_IN qualitative_JJ measurement_NN
          accuracy_NN was_VBD defined_VBN as_IN described_VBN above_IN for_IN the_DT example_NN
          of_IN Mint_NNP 2_CD ._. An_DT antibody_NN or_CC antigen_NN was_VBD considered_VBN to_TO
          perform_VB satisfactorily_RB for_IN qualitative_JJ measurement_NN at_IN a_DT
          specified_VBN concentration_NN if_IN the_DT R_NN /_NN G_NNP ratio_NN measured_VBN at_IN 100_CD %_NN
          of_IN the_DT replicate_VB spots_NNS exceeded_VBD the_DT threshold_NN whenever_WRB
          the_DT target_NN protein_NN was_VBD present_JJ at_IN or_CC above_IN the_DT specified_VBN
          concentration_NN ._. The_DT fraction_NN of_IN the_DT 115_CD antibodies_NNS and_CC
          antigens_NNS that_WDT satisfied_VBD this_DT standard_NN for_IN qualitative_JJ
          measurement_NN was_VBD plotted_VBD as_IN a_DT function_NN of_IN analyte_NN
          concentration_NN (_( Figure_NN 5_CD a_DT )_) ._. Over_IN 60_CD %_NN of_IN the_DT arrayed_JJ
          antibodies_NNS and_CC over_IN 80_CD %_NN of_IN the_DT arrayed_JJ antigens_NNS met_VBD the_DT
          criteria_NNS at_IN the_DT highest_JJS analyte_NN concentration_NN tested_VBN (_( 1_CD ._. 6_CD
          μg_NN /_NN ml_NN and_CC 340_CD ng_NN /_NN ml_NN ,_, respectively_RB )_) ,_, and_CC both_DT percentages_NNS
          decreased_VBD with_IN decreasing_VBG analyte_NN concentration_NN ._. The_DT
          performance_NN of_IN the_DT antigen_NN microarrays_NNS was_VBD better_JJR than_IN
          that_DT of_IN the_DT antibody_NN microarrays_NNS over_IN the_DT entire_JJ
          concentration_NN range_NN ._.
          Similarly_RB ,_, we_PRP plotted_VBD the_DT percentage_NN of_IN antibodies_NNS and_CC
          antigens_NNS that_WDT provided_VBD satisfactory_JJ quantitative_JJ accuracy_NN
          as_IN a_DT function_NN of_IN analyte_NN concentration_NN (_( Figure_NN 5_CD b_SYM )_) ._.
          Detection_NNP was_VBD considered_VBN quantitatively_RB accurate_JJ if_IN the_DT
          above_JJ criterion_NN for_IN qualitative_JJ accuracy_NN was_VBD fulfilled_VBN
          and_CC the_DT median_JJ R_NN /_NN G_NNP ratio_NN was_VBD within_IN a_DT factor_NN of_IN two_CD of_IN
          the_DT known_VBN concentration_NN ratio_NN ._. Nearly_RB half_NN of_IN the_DT
          antigens_NNS provided_VBN quantitatively_RB accurate_JJ measurements_NNS at_IN
          concentrations_NNS above_IN 100_CD ng_NN /_NN ml_NN ,_, and_CC the_DT percentage_NN
          decreased_VBD with_IN decreasing_VBG antibody_NN concentration_NN ._. A_DT
          smaller_JJR fraction_NN of_IN the_DT tested_VBN antibodies_NNS gave_VBD accurate_JJ
          quantitation_NN of_IN soluble_JJ antigen_NN ._. (_( See_VB the_DT web_NN supplement_NN
          [_NN 22_CD ]_NN and_CC Additional_JJ data_NNS files_NNS available_JJ with_IN this_DT
          article_NN for_IN quantitative_JJ data_NNS on_IN the_DT entire_JJ
          antibody_NN /_NN antigen_NN set_VBN ._. )_)
          We_PRP believe_VBP that_IN the_DT differences_NNS in_IN the_DT performance_NN of_IN
          the_DT antibody_NN and_CC antigen_NN arrays_NNS are_VBP likely_JJ to_TO be_VB
          explained_VBN by_IN differences_NNS in_IN dye_NN labeling_VBG and_CC protein_NN
          stability_NN ._. Antibodies_NNP of_IN varying_VBG specificities_NNS all_DT have_VBP
          very_RB similar_JJ overall_JJ structures_NNS ,_, and_CC all_DT antibodies_NNS
          irrespective_RB of_IN specificity_NN can_MD be_VB labeled_VBN with_IN the_DT
          NHS-activated_NNP dyes_NNS at_IN lysine_NN residues_NNS in_IN the_DT Fc_NNP region_NN ._.
          In_IN contrast_NN ,_, many_JJ antigen_NN proteins_NNS do_VBP not_RB have_VB easily_RB
          accessible_JJ amines_NNS ._. Inefficient_NNP ,_, highly_RB variable_JJ ,_, or_CC
          non-existent_JJ labeling_VBG may_MD explain_VB the_DT 30_CD -_: 40_CD %_NN fewer_RBR
          antigen-antibody_JJ pairs_NNS that_WDT performed_VBD satisfactorily_RB in_IN
          qualitative_JJ detection_NN in_IN the_DT antibody_NN microarray_NN format_NN ,_,
          as_IN compared_VBN to_TO the_DT antigen_NN microarray_NN format_NN ._. Antibodies_NNP
          are_VBP also_RB relatively_RB stable_JJ proteins_NNS ,_, and_CC their_PRP$ greater_JJR
          stability_NN in_IN solution_NN ,_, relative_JJ to_TO their_PRP$ cognate_NN
          antigens_NNS ,_, may_MD also_RB contribute_VB to_TO the_DT better_JJR performance_NN
          of_IN the_DT antigen_NN arrays_NNS ._.
        
        
          Background_NNP effects_NNS and_CC detection_NN limits_NNS
          Because_IN the_DT background_NN signal_NN from_IN non-specific_JJ
          adsorption_NN of_IN labeled_VBN protein_NN increases_NNS with_IN increasing_VBG
          protein_NN concentration_NN ,_, the_DT detection_NN of_IN a_DT specific_JJ target_NN
          protein_NN is_VBZ limited_VBN not_RB only_RB by_IN its_PRP$ concentration_NN ,_, but_CC
          also_RB by_IN the_DT concentration_NN of_IN the_DT non-cognate_JJ proteins_NNS in_IN
          the_DT mixture_NN ._. We_PRP therefore_RB investigated_VBD the_DT effect_NN of_IN
          protein_NN background_NN on_IN quantitation_NN ,_, by_IN adding_VBG varying_VBG
          concentrations_NNS of_IN fetal_JJ calf_NN serum_NN (_( FCS_NNP )_) to_TO the_DT set_NN of_IN
          six_CD antigen_NN mixes_VBZ ,_, increasing_VBG the_DT overall_JJ protein_NN
          concentrations_NNS by_IN 10_CD -_: fold_VB and_CC 100_CD -_: fold_VB before_IN labeling_VBG
          and_CC detection_NN (_( Figure_NN 6_CD )_) ._. The_DT images_NNS at_IN the_DT top_NN of_IN Figure_NN
          6_CD show_NN details_NNS from_IN one_CD array_NN in_IN each_DT set_VBN ._. The_DT background_NN
          fluorescence_NN was_VBD about_IN ten-fold_JJ higher_JJR at_IN the_DT higher_JJR
          protein_NN concentration_NN ._. The_DT spots_NNS in_IN the_DT right_JJ image_NN are_VBP
          much_RB less_RBR clear_JJ against_IN the_DT high_JJ background_NN ,_, but_CC the_DT
          fluorescent_NN signals_NNS are_VBP still_RB measurable_JJ ._. Higher_JJR overall_JJ
          protein_NN concentrations_NNS significantly_RB reduced_VBD the_DT
          precision_NN of_IN the_DT measurements_NNS of_IN specific_JJ proteins_NNS ,_,
          presumably_RB because_IN of_IN either_DT the_DT increased_VBN complexity_NN of_IN
          the_DT mixture_NN or_CC the_DT higher_JJR background_NN ._. For_IN example_NN ,_, the_DT
          anti-_NN Flag_NNP spots_NNS showed_VBD good_JJ quantitation_NN of_IN Flag-tagged_NNP
          Bacterial_NNP Alkaline_NNP Phosphatase_NNP (_( Flag-_NNP BAP_NNP )_) down_RB to_TO an_DT
          absolute_JJ concentration_NN of_IN 1_CD ng_NN /_NN ml_NN and_CC a_DT partial_JJ
          concentration_NN of_IN 10_CD -_: 6_CD ,_, when_WRB measured_VBN in_IN solution_NN at_IN a_DT
          total_JJ protein_NN concentration_NN of_IN 600_CD μg_NN /_NN ml_NN ._. In_IN a_DT 6_CD ,_, 000_CD
          μg_NN /_NN ml_NN protein_NN solution_NN the_DT data_NNS were_VBD very_RB noisy_NN below_IN
          approximately_RB 100_CD ng_NN /_NN ml_NN Flag-_NNP BAP_NNP ._. Likewise_RB ,_, anti-_NN SOD_NNP and_CC
          anti-_NN HCG_NNP showed_VBD increased_VBN dispersion_NN and_CC decreased_VBD
          linearity_NN when_WRB measured_VBN in_IN a_DT higher_JJR total_JJ protein_NN
          concentration_NN ._. Higher_JJR background_NN at_IN higher_JJR protein_NN
          concentrations_NNS is_VBZ probably_RB the_DT major_JJ cause_NN of_IN the_DT
          diminished_VBN performance_NN ,_, since_IN at_IN equivalent_NN partial_JJ
          concentrations_NNS the_DT measurements_NNS were_VBD noisier_NN at_IN higher_JJR
          absolute_JJ protein_NN concentrations_NNS ._. For_IN example_NN ,_, at_IN a_DT
          partial_JJ concentration_NN of_IN 4_CD ×_NN 10_CD -_: 5_CD the_DT measurements_NNS of_IN SOD_NNP
          were_VBD very_RB noisy_NN in_IN the_DT high-serum_JJ samples_NNS ,_, but_CC remained_VBD
          closely_RB correlated_JJ with_IN the_DT ideal_JJ response_NN in_IN the_DT
          lower-serum_JJ samples_NNS ._. We_PRP conclude_VBP from_IN this_DT experiment_NN
          that_IN antibody_NN microarrays_NNS can_MD allow_VB detection_NN of_IN a_DT
          specific_JJ target_NN protein_NN at_IN concentrations_NNS below_IN 1_CD ng_NN /_NN ml_NN
          and_CC partial_JJ concentrations_NNS below_IN 10_CD -_: 6_CD ._. At_IN least_JJS for_IN the_DT
          present_NN ,_, however_RB ,_, the_DT total_JJ protein_NN concentration_NN in_IN a_DT
          sample_NN to_TO be_VB analyzed_VBN using_VBG this_DT system_NN should_MD be_VB less_JJR
          than_IN 1_CD mg_NN /_NN ml_NN for_IN optimal_NN performance_NN ._. A_DT reduction_NN in_IN
          background_NN through_IN improved_VBN blocking_VBG of_IN non-specific_JJ
          adsorption_NN should_MD further_VB lower_VB the_DT detection_NN limits_NNS ._.
          We_PRP also_RB investigated_VBD the_DT detection_NN limits_NNS using_VBG the_DT
          antigen_NN arrays_NNS (_( Figure_NN 7_CD )_) ._. The_DT six_CD antibody_NN mixes_VBZ were_VBD
          added_VBN to_TO either_CC a_DT 10_CD -_: fold_VB or_CC a_DT 100_CD -_: fold_VB excess_JJ (_( by_IN total_JJ
          protein_NN mass_NN )_) of_IN FCS_NNP ._. The_DT high-concentration_JJ set_VBN was_VBD
          diluted_VBN 10_CD -_: fold_VB ,_, so_IN that_IN the_DT total_JJ protein_NN concentration_NN
          was_VBD equivalent_NN in_IN the_DT two_CD sets_NNS of_IN protein_NN mixtures_NNS ._. The_DT
          images_NNS at_IN the_DT top_NN of_IN Figure_NN 7_CD show_NN a_DT detail_NN of_IN a_DT
          microarray_NN from_IN the_DT analysis_NN of_IN each_DT set_VBN ._. The_DT background_NN
          is_VBZ very_RB similar_JJ between_IN the_DT images_NNS ,_, but_CC the_DT fluorescence_NN
          intensity_NN of_IN the_DT spots_NNS is_VBZ greatly_RB reduced_VBN as_IN the_DT partial_JJ
          and_CC absolute_JJ concentration_NN of_IN the_DT cognate_NN antibodies_NNS
          decreases_NNS ._. The_DT graphs_NNS below_IN the_DT left_NN image_NN all_DT show_NN good_JJ
          linearity_NN down_IN to_TO 0_CD ._. 3_CD ng_NN /_NN ml_NN and_CC a_DT 3_CD ×_NN 10_CD -_: 6_CD partial_JJ
          concentration_NN ._. The_DT graphs_NNS on_IN the_DT right_NN of_IN Figure_NN 7_CD show_NN
          similar_JJ performance_NN at_IN similar_JJ partial_JJ concentrations_NNS ,_,
          but_CC more_JJR noise_NN at_IN the_DT lowest_JJS concentration_NN ,_, where_WRB the_DT
          specific_JJ fluorescence_NN signals_NNS were_VBD low_JJ ._. The_DT level_NN of_IN
          performance_NN depicted_VBN here_RB is_VBZ representative_NN of_IN about_IN 20_CD
          (_( 18_CD %_NN )_) of_IN the_DT antibody_NN /_NN antigen_NN pairs_NNS tested_VBN ._. We_PRP conclude_VBP
          from_IN this_DT experiment_NN that_DT detection_NN down_IN to_TO
          concentrations_NNS of_IN 0_CD ._. 1_CD ng_NN /_NN ml_NN and_CC partial_JJ concentrations_NNS of_IN
          10_CD -_: 6_CD is_VBZ possible_JJ using_VBG antigen_NN arrays_NNS ._. Reduction_NNP of_IN total_JJ
          protein_NN concentration_NN below_IN approximately_RB 100_CD μg_NN /_NN ml_NN did_VBD
          not_RB improve_VB the_DT signal-to-noise_JJ ratio_NN ._.
        
      
      
        Discussion_NNP
        We_PRP have_VBP shown_VBN that_IN a_DT simple_JJ microarray_NN assay_NN ,_, using_VBG
        comparative_JJ fluorescence_NN ,_, allows_VBZ simultaneous_JJ detection_NN and_CC
        quantitation_NN of_IN multiple_JJ proteins_NNS in_IN a_DT miniaturized_VBN ,_,
        low-sample_JJ consumption_NN format_NN ._. Microarrays_NNP of_IN antigens_NNS
        allowed_VBD detection_NN and_CC quantitation_NN of_IN specific_JJ antibodies_NNS
        down_RB to_TO partial_JJ concentrations_NNS of_IN less_JJR than_IN 10_CD -_: 6_CD and_CC
        absolute_JJ concentrations_NNS of_IN 100_CD pg_NN /_NN ml_NN ._. Microarrays_NNP of_IN
        antibodies_NNS allowed_VBD detection_NN and_CC quantitation_NN of_IN cognate_NN
        antigens_NNS at_IN concentrations_NNS as_RB low_JJ as_IN 1_CD ng_NN /_NN ml_NN and_CC partial_JJ
        concentrations_NNS of_IN 10_CD -_: 6_CD ._. In_IN comparison_NN to_TO other_JJ
        high-throughput_JJ protein_NN detection_NN methods_NNS ,_, particularly_RB
        two-dimensional_JJ gel_NN electrophoresis_NNS ,_, the_DT detection_NN limit_NN of_IN
        protein_NN microarrays_NNS compares_VBZ favorably_RB ._. Around_IN 1_CD ng_NN of_IN any_DT
        protein_NN is_VBZ required_VBN for_IN detection_NN on_IN a_DT two-dimensional_JJ gel_NN
        [_NN 1_CD ]_NN ._. Several_JJ antibodies_NNS on_IN the_DT microarray_NN had_VBD detection_NN
        limits_NNS around_IN 1_CD ng_NN /_NN ml_NN ,_, corresponding_JJ to_TO an_DT absolute_JJ
        detection_NN limit_NN of_IN only_RB 20_CD pg_NN of_IN protein_NN ,_, in_IN the_DT 20_CD μl_NN
        probe_NN volume_NN ._.
        Our_PRP$ results_NNS suggest_VBP directions_NNS for_IN further_JJ improvement_NN
        of_IN the_DT accuracy_NN in_IN quantitation_NN ,_, such_JJ as_IN the_DT inclusion_NN of_IN
        internal_JJ calibration_NN proteins_NNS to_TO control_VB for_IN variation_NN in_IN
        fluorescent_NN labeling_VBG ,_, and_CC the_DT adjustment_NN of_IN dye_NN labeling_VBG
        conditions_NNS to_TO reduce_VB the_DT variation_NN ._. The_DT detection_NN limits_NNS
        are_VBP likely_JJ to_TO be_VB improved_VBN by_IN better_RB passivation_NN of_IN the_DT
        array_NN surface_NN ,_, by_IN using_VBG antibodies_NNS with_IN higher_JJR affinities_NNS ,_,
        and_CC by_IN reducing_VBG the_DT complexity_NN of_IN the_DT protein_NN solution_NN
        through_IN fractionation_NN ._. The_DT antibodies_NNS we_PRP used_VBD in_IN this_DT
        analysis_NN were_VBD not_RB optimized_JJ for_IN affinity_NN and_CC specificity_NN ._.
        Antibodies_NNP used_VBD in_IN clinical_JJ diagnostic_JJ applications_NNS are_VBP
        commonly_RB selected_VBN for_IN affinities_NNS orders_NNS of_IN magnitude_NN higher_JJR
        than_IN those_DT of_IN the_DT research-grade_JJ antibodies_NNS we_PRP used_VBD in_IN this_DT
        pilot_NN study_NN ._. The_DT use_NN of_IN clinical-grade_JJ high-affinity_JJ
        antibodies_NNS in_IN this_DT format_NN would_MD presumably_RB allow_VB a_DT
        corresponding_JJ increase_NN in_IN sensitivity_NN ._.
        Many_JJ of_IN the_DT tested_VBN antibody_NN /_NN antigen_NN pairs_NNS allowed_VBD
        parallel_JJ detection_NN of_IN proteins_NNS in_IN a_DT microarray_NN format_NN at_IN
        concentrations_NNS suitable_JJ for_IN measurement_NN of_IN clinically_RB
        important_JJ proteins_NNS in_IN patient_NN samples_NNS ._. For_IN example_NN ,_,
        concentrations_NNS of_IN 15_CD μg_NN /_NN ml_NN ,_, 5_CD μg_NN /_NN ml_NN ,_, and_CC 35_CD μg_NN /_NN ml_NN are_VBP
        routinely_RB used_VBN as_IN threshold_NN prognostic_JJ values_NNS for_IN the_DT
        breast_NN cancer_NN markers_NNS c-erb_JJ B-_NNP 2_CD ,_, CEA_NNP ,_, and_CC CA_NNP 15_CD ._. 3_LS ,_,
        respectively_RB [_NN 23_CD ]_NN ._. The_DT partial_JJ concentration_NN of_IN a_DT protein_NN
        at_IN 20_CD μg_NN /_NN ml_NN in_IN the_DT blood_NN serum_NN ,_, using_VBG an_DT average_JJ total_JJ
        protein_NN concentration_NN of_IN 60_CD mg_NN /_NN ml_NN ,_, is_VBZ 3_CD ×_NN 10_CD -_: 4_CD ,_, within_IN the_DT
        range_NN of_IN 25_CD %_NN of_IN the_DT antibodies_NNS tested_VBN and_CC 70_CD %_NN of_IN the_DT
        antigens_NNS tested_VBN ._. The_DT prostate_NN cancer_NN marker_NN prostate_NN
        specific_JJ antigen_NN (_( PSA_NNP )_) is_VBZ clinically_RB useful_JJ in_IN the_DT 10_CD -_: 20_CD
        ng_NN /_NN ml_NN range_NN [_NN 24_CD ]_NN ,_, or_CC a_DT partial_JJ concentration_NN of_IN 3_CD ×_NN 10_CD -_: 7_CD ._.
        The_DT best_JJS antibody_NN /_NN antigen_NN pairs_NNS tested_VBN had_VBD detection_NN limits_NNS
        in_IN this_DT range_NN ._. The_DT prospects_NNS for_IN clinical_JJ application_NN of_IN
        antigen_NN microarrays_NNS in_IN monitoring_VBG antibody_NN response_NN to_TO
        immunization_NN ,_, infection_NN ,_, or_CC other_JJ disorders_NNS ,_, are_VBP extremely_RB
        promising_JJ ._. A_DT natural_JJ immune_JJ response_NN typically_RB yields_VBZ
        specific_JJ IgG_NNP concentrations_NNS ranging_VBG from_IN approximately_RB 10_CD
        ng_NN /_NN ml_NN [_NN 25_CD ]_NN to_TO over_IN 3_CD μg_NN /_NN ml_NN ,_, [_NN 26_CD ]_NN well_RB within_IN the_DT
        detection_NN limits_NNS most_JJS of_IN the_DT antigens_NNS tested_VBN ._.
        In_IN conclusion_NN ,_, these_DT experiments_NNS demonstrate_VBP that_IN a_DT
        comparative_JJ fluorescence_NN assay_NN using_VBG microarrays_NNS of_IN
        antibodies_NNS and_CC antigens_NNS can_MD provide_VB a_DT practical_JJ approach_NN to_TO
        specific_JJ ,_, quantitative_JJ ,_, and_CC highly_RB parallel_JJ detection_NN of_IN
        proteins_NNS at_IN physiologically_RB relevant_JJ concentrations_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Preparation_NNP of_IN arrays_NNS
          Ninety-four_NNP antibody_NN /_NN antigen_NN pairs_NNS were_VBD provided_VBN by_IN BD_NNP
          Transduction_NNP Laboratories_NNPS (_( Cincinnati_NNP ,_, OH_NNP )_) ,_, six_CD pairs_NNS
          were_VBD provided_VBN by_IN Research_NNP Genetics_NNP (_( Huntsville_NNP ,_, AL_NNP )_) ,_, and_CC
          15_CD pairs_NNS were_VBD purchased_VBN from_IN Sigma_NNP Chemical_NNP ._. Antibodies_NNP
          and_CC antigens_NNS that_WDT were_VBD provided_VBN in_IN glycerol_NN solutions_NNS
          were_VBD transferred_VBN to_TO a_DT glycerol-free_JJ ,_, phosphate-buffered_JJ
          saline_NN (_( PBS_NNP )_) solution_NN (_( 137_CD mM_NN NaCl_NNP ,_, 2_CD ._. 7_CD mM_NN KCl_NNP ,_, 4_CD ._. 3_CD mM_NN Na_NNP
          
          2_LS HPO_NNP 
          4_CD ,_, 1_CD ._. 4_CD mM_NN KH_NNP 
          2_CD PO_NNP 
          4_CD ,_, pH_NN 7_CD ._. 4_LS )_) using_VBG a_DT BioRad_NNP Biospin_NNP P_NN 6_CD
          column_NN ._. Antibody_NNP and_CC antigen_NN solutions_NNS were_VBD prepared_VBN at_IN
          0_CD ._. 1_CD -_: 0_CD ._. 3_LS mg_NN /_NN ml_NN in_IN 384_CD -_: well_RB plates_NNS ,_, using_VBG approximately_RB 4_CD
          μl_NN per_IN well_RB ._. A_DT robotic_JJ arrayer_NN spotted_VBD the_DT protein_NN
          solutions_NNS in_IN an_DT ordered_VBN array_NN onto_IN poly-_NN L-_NNP lysine_NN coated_JJ
          microscope_NN slides_NNS at_IN a_DT 375_CD μm_NN spacing_VBG using_VBG 16_CD steel_NN
          tips_NNS ._. The_DT coated_JJ slides_NNS were_VBD prepared_VBN as_RB previously_RB
          reported_VBD [_NN 27_CD ]_NN or_CC purchased_VBN from_IN CEL_NNP Associates_NNPS (_( Houston_NNP ,_,
          TX_NNP )_) ._. Briefly_NNP ,_, glass_NN microscope_NN slides_NNS were_VBD cleaned_VBN in_IN 2_CD ._. 5_CD
          M_NNP NaOH_NNP for_IN 2_CD h_NN ,_, rinsed_JJ thoroughly_RB in_IN ultra-pure_JJ H_NNP 
          2_CD O_NNP ,_, soaked_JJ for_IN 1_CD hour_NN in_IN a_DT 3_CD %_NN
          poly-_NN L-_NNP lysine_NN solution_NN in_IN PBS_NNP ,_, rinsed_JJ in_IN ultra-pure_JJ H_NNP 
          2_CD O_NNP ,_, spun_VBD dry_JJ ,_, and_CC further_RBR dried_VBD for_IN 1_CD
          h_NN at_IN 80_CD °_NN C_NNP in_IN a_DT vacuum_NN oven_NN ._. The_DT resulting_VBG microarrays_NNS
          were_VBD sealed_VBN in_IN a_DT slide_NN box_NN and_CC stored_VBD at_IN 4_CD °_NN C_NNP ._. The_DT
          location_NN of_IN the_DT array_NN of_IN spots_NNS was_VBD delineated_JJ on_IN the_DT back_JJ
          sides_NNS of_IN the_DT arrays_NNS with_IN a_DT diamond_NN scribe_NN (_( the_DT spots_NNS
          disappear_VBP after_IN washing_VBG )_) ._. The_DT arrays_NNS were_VBD rinsed_JJ briefly_NN
          in_IN a_DT 3_CD %_NN non-fat_JJ milk_NN /_NN PBS_NNP /_NN 0_CD ._. 1_LS %_NN Tween-_NNP 20_CD solution_NN to_TO remove_VB
          unbound_NN protein_NN ._. They_PRP were_VBD transferred_VBN immediately_RB to_TO a_DT
          3_CD %_NN non-fat_JJ milk_NN /_NN PBS_NNP /_NN 0_CD ._. 02_CD %_NN sodium_NN azide_NN blocking_VBG solution_NN
          and_CC allowed_VBN to_TO sit_VB overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT milk_NN solution_NN
          had_VBD been_VBN first_RB spun_VBN for_IN 10_CD min_NN at_IN 10_CD ,_, 000_CD ×_NN g_SYM to_TO remove_VB
          particulate_NN matter_NN ._. Excess_NNP milk_NN was_VBD removed_VBN in_IN three_CD room_NN
          temperature_NN PBS_NNP washes_NNS of_IN 1_CD min_NN each_DT ,_, and_CC the_DT arrays_NNS
          remained_VBD in_IN the_DT final_JJ wash_NN until_IN application_NN of_IN the_DT probe_NN
          solution_NN (_( see_VB below_IN )_) ._.
        
        
          Preparation_NNP of_IN protein_NN solutions_NNS
          Protein_NNP solutions_NNS and_CC NHS-ester_NNP activated_VBN Cy_NNP 3_CD and_CC Cy_NNP 5_CD
          solutions_NNS (_( Amersham_NNP PA_NNP 23001_CD and_CC PA_NNP 25001_CD )_) were_VBD prepared_VBN in_IN
          a_DT 0_CD ._. 1_CD M_NNP pH_NN 8_CD ._. 0_CD sodium_NN carbonate_NN buffer_NN ._. The_DT protein_NN and_CC
          dye_NN solutions_NNS were_VBD mixed_JJ together_RB so_IN that_IN the_DT final_JJ
          protein_NN concentration_NN was_VBD 0_CD ._. 2_CD -_: 2_CD mg_NN /_NN ml_NN and_CC the_DT final_JJ dye_NN
          concentration_NN was_VBD 100_CD -_: 300_CD μM_NN ._. Normally_RB approximately_RB 15_CD
          μg_NN protein_NN was_VBD labeled_VBN per_IN array_NN ._. The_DT reactions_NNS were_VBD
          allowed_VBN to_TO sit_VB in_IN the_DT dark_NN for_IN 45_CD min_NN and_CC then_RB quenched_JJ
          by_IN the_DT addition_NN of_IN a_DT tenth_NN volume_NN 1_CD M_NNP pH_NN 8_CD Tris_NNP base_NN (_( a_DT
          500_CD -_: fold_VB molar_NN excess_NN of_IN quencher_NN )_) ._. The_DT reaction_NN
          solutions_NNS were_VBD brought_VBN to_TO 0_CD ._. 5_CD ml_NN with_IN PBS_NNP and_CC then_RB loaded_VBN
          into_IN microconcentrator_NN spin_NN columns_NNS (_( Amicon_NNP Microcon_NNP 10_CD )_)
          with_IN a_DT 10_CD ,_, 000_CD Da_NNP molecular_JJ weight_NN cutoff_NN ._. After_IN
          centrifugation_NN to_TO reduce_VB the_DT volume_NN to_TO approximately_RB 10_CD
          μl_NN (_( approximately_RB 20_CD min_NN )_) ,_, a_DT 3_CD %_NN non-fat_JJ milk_NN blocking_VBG
          solution_NN was_VBD added_VBN to_TO each_DT Cy_NNP 5_CD -_: labeled_VBN solution_NN such_JJ that_IN
          25_CD μl_NN milk_NN was_VBD added_VBN for_IN each_DT array_NN to_TO be_VB generated_VBN from_IN
          the_DT mix_NN ._. (_( The_DT milk_NN had_VBD been_VBN first_RB spun_VBN down_RB as_IN above_IN ._. )_)
          The_DT volume_NN was_VBD again_RB brought_VBN to_TO 0_CD ._. 5_CD ml_NN with_IN PBS_NNP and_CC the_DT
          sample_NN again_RB centrifuged_JJ to_TO ~_NN 10_CD μl_NN ._. The_DT Cy_NNP 3_CD -_: labeled_VBN
          reference_NN mix_NN was_VBD divided_VBN equally_RB among_IN the_DT Cy_NNP 5_CD -_: labeled_VBN
          mixes_VBZ ,_, and_CC PBS_NNP was_VBD added_VBN to_TO each_DT to_TO achieve_VB 25_CD μl_NN for_IN
          each_DT array_NN ._. Finally_RB ,_, the_DT mixes_VBZ were_VBD filtered_VBN with_IN a_DT 0_CD ._. 45_CD
          μm_NN spin_NN filter_NN (_( Millipore_NNP )_) by_IN centrifugation_NN at_IN 10_CD ,_, 000_CD ×_NN
          g_SYM for_IN 2_CD min_NN ._.
        
        
          Detection_NNP
          Each_DT microarray_NN was_VBD removed_VBN individually_RB from_IN the_DT PBS_NNP
          wash_NN (_( see_VB above_IN )_) ,_, and_CC excess_JJ liquid_NN was_VBD shaken_VBN off_RP ._.
          Without_IN allowing_VBG the_DT array_NN to_TO dry_VB ,_, 25_CD μl_NN dye-labeled_JJ
          protein_NN solution_NN was_VBD applied_VBN to_TO the_DT surface_NN within_IN the_DT
          marked_VBN boundaries_NNS ._. A_DT 24_CD ×_NN 30_CD mm_NN cover_NN slip_VB was_VBD placed_VBN
          over_IN the_DT solution_NN ._. The_DT arrays_NNS were_VBD sealed_VBN in_IN a_DT chamber_NN
          with_IN an_DT under-layer_JJ of_IN PBS_NNP to_TO provide_VB humidification_NN ,_,
          after_IN which_WDT they_PRP sat_VBD at_IN 4_CD °_NN C_NNP for_IN 2_CD h_NN ._. The_DT arrays_NNS were_VBD
          dunked_JJ briefly_NN in_IN PBS_NNP to_TO remove_VB the_DT protein_NN solution_NN and_CC
          the_DT cover_NN slip_NN ,_, and_CC they_PRP were_VBD then_RB allowed_VBN to_TO rock_VB gently_RB
          in_IN PBS_NNP /_NN 0_CD ._. 1_LS %_NN Tween-_NNP 20_CD solution_NN for_IN 20_CD min_NN ._. The_DT arrays_NNS were_VBD
          then_RB washed_VBN twice_RB in_IN PBS_NNP for_IN 5_CD -_: 10_CD min_NN each_DT and_CC twice_RB in_IN H_NNP
          
          2_LS O_NNP for_IN 5_CD -_: 10_CD min_NN each_DT ._. All_DT washes_NNS were_VBD
          at_IN room_NN temperature_NN ._. After_IN spinning_JJ to_TO dryness_NN in_IN a_DT
          clinical_JJ centrifuge_NN equipped_VBN with_IN plate_NN carriers_NNS
          (_( Beckman_NNP )_) ,_, the_DT arrays_NNS were_VBD scanned_JJ in_IN an_DT Axon_NNP
          Laboratories_NNPS (_( Palo_NNP Alto_NNP ,_, CA_NNP )_) scanner_NN using_VBG 532_CD nm_NN and_CC 635_CD
          nm_NN lasers_NNS ._.
        
        
          Analysis_NNP
          The_DT relative_JJ concentration_NN of_IN each_DT protein_NN in_IN two_CD
          separate_JJ dye-labeled_JJ pools_NNS was_VBD determined_VBN by_IN comparing_VBG
          the_DT fluorescence_NN intensities_NNS in_IN the_DT Cy_NNP 3_CD -_: and_CC Cy_NNP 5_CD -_: specific_JJ
          channels_NNS at_IN each_DT spot_NN ._. The_DT location_NN of_IN each_DT analyte_NN spot_NN
          on_IN the_DT array_NN was_VBD outlined_VBN using_VBG the_DT gridding_VBG software_NN
          GenePix_NNP (_( Axon_NNP Laboratories_NNPS ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) and_CC ScanAlyze_NNP
          [_NN 28_CD ]_NN ._. The_DT background_NN ,_, calculated_VBN as_IN the_DT median_NN of_IN pixel_NN
          intensities_NNS from_IN the_DT local_JJ area_NN around_IN each_DT spot_NN ,_, was_VBD
          subtracted_VBN from_IN the_DT average_JJ pixel_NN intensity_NN within_IN each_DT
          spot_NN ._. The_DT background-subtracted_JJ values_NNS in_IN the_DT red_JJ channel_NN
          were_VBD multiplied_VBN by_IN a_DT normalization_NN factor_NN to_TO correct_VB for_IN
          detection_NN differences_NNS in_IN the_DT two_CD channels_NNS ._. The_DT
          normalization_NN factor_NN was_VBD found_VBN by_IN comparing_VBG the_DT red_JJ /_NN green_JJ
          ratios_NNS of_IN three_CD to_TO four_CD well-behaved_JJ antibodies_NNS or_CC
          antigens_NNS ,_, which_WDT served_VBD as_IN internal_JJ standards_NNS ,_, to_TO the_DT
          ratio_NN of_IN the_DT known_VBN concentrations_NNS ._. A_DT factor_NN was_VBD
          calculated_VBN which_WDT ,_, when_WRB multiplied_VBN with_IN the_DT signal_NN in_IN the_DT
          red_JJ channel_NN ,_, minimized_VBN the_DT difference_NN between_IN the_DT ideal_JJ
          and_CC observed_VBD red_JJ /_NN green_JJ ratios_NNS ._. A_DT separate_JJ normalization_NN
          factor_NN was_VBD calculated_VBN for_IN each_DT array_NN ._. To_TO normalize_VB the_DT
          ratios_NNS for_IN the_DT antigens_NNS or_CC antibodies_NNS that_WDT were_VBD used_VBN in_IN
          calculating_VBG the_DT factor_NN ,_, a_DT separate_JJ factor_NN was_VBD used_VBN in_IN
          which_WDT that_IN particular_JJ antibody_NN or_CC antigen_NN was_VBD dropped_VBN
          from_IN the_DT calculation_NN (_( that_WDT is_VBZ ,_, a_DT spot_NN was_VBD never_RB used_VBN to_TO
          normalize_VB itself_PRP )_) ._. Finally_RB ,_, the_DT ratios_NNS of_IN the_DT
          background-subtracted_JJ ,_, normalized_JJ signal_NN intensities_NNS were_VBD
          calculated_VBN to_TO estimate_VB the_DT relative_JJ concentrations_NNS
          between_IN proteins_NNS in_IN the_DT separately_RB labeled_VBN pools_NNS ._.
        
      
      
        Additional_JJ data_NNS
        Additional_JJ data_NNS files_NNS available_JJ with_IN the_DT online_NN version_NN
        of_IN this_DT article_NN include_VBP Excel_NNP files_NNS of_IN quantitative_JJ data_NNS of_IN
        the_DT whole_JJ antibody_NN /_NN antigen_NN data_NNS set_VBD [_NN 22_CD ]_NN ._.
        The_DT following_VBG data_NN are_VBP available_JJ :_:
        Normalization_NNP factors_NNS and_CC protein_NN concentrations_NNS
        used_VBN
        Additional_JJ data_NNS file_VBP 1_CD
        Normalization_NNP factors_NNS and_CC protein_NN concentrations_NNS
        used_VBN
        Normalization_NNP factors_NNS and_CC protein_NN concentrations_NNS
        used_VBN ._.
        Click_NNP here_RB for_IN file_NN
        Raw_NNP data_NNS and_CC analysis_NN for_IN antibody_NN arrays_NNS in_IN figures_NNS 1_CD ,_,
        3_CD ,_, and_CC 5_CD
        Additional_JJ data_NNS file_VBP 2_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN antibody_NN arrays_NNS in_IN figures_NNS 1_CD ,_,
        3_CD ,_, and_CC 5_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN antibody_NN arrays_NNS in_IN figures_NNS 1_CD ,_,
        3_CD ,_, and_CC 5_CD ._.
        Click_NNP here_RB for_IN file_NN
        Raw_NNP data_NNS and_CC analysis_NN for_IN antigen_NN arrays_NNS in_IN figures_NNS 2_CD ,_,
        4_CD ,_, 5_CD ,_, and_CC 7_CD
        Additional_JJ data_NNS file_VBP 3_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN antibody_NN arrays_NNS in_IN figures_NNS 2_CD ,_,
        4_CD ,_, 5_CD ,_, and_CC 7_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN antibody_NN arrays_NNS in_IN figures_NNS 2_CD ,_,
        4_CD ,_, 5_CD ,_, and_CC 7_CD ._.
        Click_NNP here_RB for_IN file_NN
        Accuracy_NNP tabulations_NNS for_IN figure_NN 5_CD
        Additional_JJ data_NNS file_VBP 4_CD
        Accuracy_NNP tabulations_NNS for_IN figure_NN 5_CD
        Accuracy_NNP tabulations_NNS for_IN figure_NN 5_CD ._.
        Click_NNP here_RB for_IN file_NN
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD
        Additional_JJ data_NNS file_VBP 5_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD ._.
        Click_NNP here_RB for_IN file_NN
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD (_( continued_VBD )_)
        Additional_JJ data_NNS file_VBP 6_CD
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD (_( continued_VBD )_)
        Raw_NNP data_NNS and_CC analysis_NN for_IN figure_NN 6_CD (_( continued_VBD )_) ._.
        Click_NNP here_RB for_IN file_NN
        Additional_JJ data_NNS for_IN figure_NN 7_CD
        Additional_JJ data_NNS file_VBP 7_CD
        Additional_JJ data_NNS for_IN figure_NN 7_CD
        Additional_JJ data_NNS for_IN figure_NN 7_CD ._.
        Click_NNP here_RB for_IN file_NN
        Antibody_NNP informationfrom_NN Transduction_NNP Labs_NNPS ,_, including_VBG
        catalog_NN numbers_NNS ,_, performance_NN in_IN other_JJ assays_NNS ,_, and_CC
        subcellular_NN location_NN of_IN antigens_NNS
        Additional_JJ data_NNS file_VBP 8_CD
        Antibody_NNP information_NN from_IN Transduction_NNP Labs_NNPS
        Antibody_NNP information_NN from_IN Transduction_NNP Labs_NNPS ,_, including_VBG
        catalog_NN numbers_NNS ,_, performance_NN in_IN other_JJ assays_NNS ,_, and_CC
        subcellular_NN location_NN of_IN antigens_NNS ._.
        Click_NNP here_RB for_IN file_NN
      
    
  
